These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
513 related items for PubMed ID: 15958833
21. HIV-1-infected children on HAART: immunologic features of three different levels of viral suppression. Zaccarelli-Filho CA, Ono E, Machado DM, Brunialti M, Succi RC, Salomão R, Kallás EG, de Moraes-Pinto MI. Cytometry B Clin Cytom; 2007 Jan 15; 72(1):14-21. PubMed ID: 17041945 [Abstract] [Full Text] [Related]
22. Progression to CMV end-organ disease in HIV-1-infected individuals despite abundance of highly differentiated CMV-specific CD8+ T-cells. Bronke C, Westerlaken GH, Miedema F, Tesselaar K, van Baarle D. Immunol Lett; 2005 Mar 15; 97(2):215-24. PubMed ID: 15752561 [Abstract] [Full Text] [Related]
24. The effect of early life cytomegalovirus infection on the immune profile of children. Ekman I, Schroderus AM, Vuorinen T, Knip M, Veijola R, Toppari J, Ilonen J, Lempainen J, Kinnunen T. Clin Immunol; 2024 Sep 15; 266():110330. PubMed ID: 39067678 [Abstract] [Full Text] [Related]
26. Multifunctional cytomegalovirus (CMV)-specific CD8(+) T cells are not restricted by telomere-related senescence in young or old adults. Riddell NE, Griffiths SJ, Rivino L, King DC, Teo GH, Henson SM, Cantisan S, Solana R, Kemeny DM, MacAry PA, Larbi A, Akbar AN. Immunology; 2015 Apr 15; 144(4):549-60. PubMed ID: 25314332 [Abstract] [Full Text] [Related]
30. Distribution and functional analysis of memory antiviral CD8 T cell responses in HIV-1 and cytomegalovirus infections. Ellefsen K, Harari A, Champagne P, Bart PA, Sékaly RP, Pantaleo G. Eur J Immunol; 2002 Dec 15; 32(12):3756-64. PubMed ID: 12516570 [Abstract] [Full Text] [Related]
31. Subclinical Cytomegalovirus DNA Is Associated with CD4 T Cell Activation and Impaired CD8 T Cell CD107a Expression in People Living with HIV despite Early Antiretroviral Therapy. Christensen-Quick A, Massanella M, Frick A, Rawlings SA, Spina C, Vargas-Meneses M, Schrier R, Nakazawa M, Anderson C, Gianella S. J Virol; 2019 Jul 01; 93(13):. PubMed ID: 31019052 [Abstract] [Full Text] [Related]
32. Primary immune responses to human CMV: a critical role for IFN-gamma-producing CD4+ T cells in protection against CMV disease. Gamadia LE, Remmerswaal EB, Weel JF, Bemelman F, van Lier RA, Ten Berge IJ. Blood; 2003 Apr 01; 101(7):2686-92. PubMed ID: 12411292 [Abstract] [Full Text] [Related]
34. Cytomegalovirus (CMV)-specific CD8+ T cells in individuals with HIV infection: correlation with protection from CMV disease. Stone SF, Price P, French MA. J Antimicrob Chemother; 2006 Apr 01; 57(4):585-8. PubMed ID: 16504998 [Abstract] [Full Text] [Related]
35. Association of CD8+ T lymphocyte subsets with the most commonly used markers to monitor HIV type 1 infection in children treated with highly active antiretroviral therapy. Navarro J, Resino S, Bellón JM, Abad ML, Gurbindo D, Fernández-Cruz E, Muñóz-Fernández MA. AIDS Res Hum Retroviruses; 2001 Apr 10; 17(6):525-32. PubMed ID: 11350666 [Abstract] [Full Text] [Related]
36. Regulatory function of cytomegalovirus-specific CD4+CD27-CD28- T cells. Tovar-Salazar A, Patterson-Bartlett J, Jesser R, Weinberg A. Virology; 2010 Mar 15; 398(2):158-67. PubMed ID: 20034645 [Abstract] [Full Text] [Related]
37. Comparisons of CD8+ T cells specific for human immunodeficiency virus, hepatitis C virus, and cytomegalovirus reveal differences in frequency, immunodominance, phenotype, and interleukin-2 responsiveness. Jagannathan P, Osborne CM, Royce C, Manion MM, Tilton JC, Li L, Fischer S, Hallahan CW, Metcalf JA, McLaughlin M, Pipeling M, McDyer JF, Manley TJ, Meier JL, Altman JD, Hertel L, Davey RT, Connors M, Migueles SA. J Virol; 2009 Mar 15; 83(6):2728-42. PubMed ID: 19129459 [Abstract] [Full Text] [Related]
38. Lower CD4+ T lymphocyte nadirs may indicate limited immune reconstitution in HIV-1 infected individuals on potent antiretroviral therapy: analysis of immunophenotypic marker results of AACTG 5067. D'Amico R, Yang Y, Mildvan D, Evans SR, Schnizlein-Bick CT, Hafner R, Webb N, Basar M, Zackin R, Jacobson MA. J Clin Immunol; 2005 Mar 15; 25(2):106-15. PubMed ID: 15821887 [Abstract] [Full Text] [Related]
39. Expansion of CMV-specific CD8+CD45RA+CD27- T cells in B-cell chronic lymphocytic leukemia. Mackus WJ, Frakking FN, Grummels A, Gamadia LE, De Bree GJ, Hamann D, Van Lier RA, Van Oers MH. Blood; 2003 Aug 01; 102(3):1057-63. PubMed ID: 12689926 [Abstract] [Full Text] [Related]